TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

Volver

Resultados 85 resultados LastUpdate Última actualización 13/11/2018 [15:27:00] pdf PDF




Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 4 nextPage   Mostrar por página


IN BODY PERFUSION SYSTEM

NºPublicación: EP3398558A1 07/11/2018

Solicitante:
ANDRETTA CARLO [CH]

Resumen de: EP3398558A1

An implantable perfusion device (2) comprises a tubular transmission line (4) with an inlet end (6), an outlet end (8) and a flow restriction element (10) located therebetween, whereby an inlet section (12) of the transmission line is defined between the inlet end and the flow restriction element and whereby an outlet section (14) of the transmission line is defined between the flow restriction element and the outlet end. Moreover, the device comprises a perfusion chamber (16) with a fluid entrance (18), a fluid exit (20) and a chamber volume (22) formed therebetween; the fluid entrance comprising at least one first microchannel platelet (24) and the fluid exit comprising at least one second microchannel platelet (26), each one of the microchannel platelets comprising at least one array of microchannels (28) defining a fluid passage between respective external and internal platelet faces, the microchannels having an opening of 0.2 to 10 µm. The fluid entrance (18) of the perfusion chamber is in fluid communication with the inlet section (12) of the transmission line; and the flow restriction element (10) is configured to establish a predetermined pressure excess in the inlet section (12) versus the outlet section (14). An artificial pancreas device comprises an implantable perfusion device wherein the perfusion chamber is loaded with islet of Langerhans cells (LC).



traducir


 

WEARABLE APPARATUS FOR CONTINUOUS BLOOD GLUCOSE MONITORING

NºPublicación: EP3397143A1 07/11/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2017185284A1

A system, a method, and a computer program product for providing wearable continuous blood glucose monitoring. In some embodiments, there is provided a method that includes receiving, at a smartwatch, an alert representative of a glucose state of a host-patient coupled to a glucose sensor; detecting, at the smartwatch, a predetermined action indicative of a request to generate a glance view providing an indication of the glucose state of the host-patient; and presenting, at the smartwatch and in response to the detecting, the glance view providing the indication of the glucose state of the host-patient.



traducir


 

INTEGRAL BLOOD GLUCOSE METER HAVING EJECTING UNIT

NºPublicación: WO2018199471A1 01/11/2018

Solicitante:
I SENS INC [KR]

Resumen de: WO2018199471A1

The present invention relates to an integral blood glucose meter, and provides an integral blood glucose meter configured so as to be capable of receiving therein a strip cartridge for holding a plurality of test strips, and to enable the test strips to be loaded one by one from the strip cartridge by linearly moving an operation knob, and thus has a simple operation method and structure and enables accurately supplying and discharging the test strips, and enables the test strips to be conveniently discharged and removed after a blood glucose measuring procedure is completed by having an ejecting unit mounted thereto that may be pressed and operated so as to enable discharging and removing the test strips loaded at a strip discharge port, and enables more convenience in use by enabling the test strips to be discharged at an adequate speed by the operating force of a user without having the test strips shooting out too forcefully, and prevents damage to the internal structure and, at the same time, enables maintaining a stable operational state by preventing external test strips and foreign substances from entering.



traducir


 

Compositions and Methods for Treating Joints

NºPublicación: US2018311272A1 01/11/2018

Solicitante:
DEPUY MITEK LLC [US]

Resumen de: US2018311272A1

Compositions and methods are provided for treating joint conditions, such as osteoarthritis and/or the pain associated therewith. The compositions and methods utilize a first component, namely hyaluronic acid (“HA”), in combination with a lyophilized second component that is effective to at least temporarily reduce the viscosity of the HA. In an exemplary embodiment, the second component is one or more glycosaminoglycans (“GAG”), such as chondroitin sulfate (“CS”), including CS4 and/or CS6, dermatan sulfate, heparin, heparan sulfate, and keratan sulfate. The composition can optionally include other joint supplements, such as glucosamine (“GlcN”)



traducir


 

INTEGRAL BLOOD GLUCOSE METER DISPLAYING INFORMATION ON NUMBER OF REMAINING TEST STRIPS

NºPublicación: WO2018199473A1 01/11/2018

Solicitante:
I SENS INC [KR]

Resumen de: WO2018199473A1

The present invention relates to an integral blood glucose meter, and provides an integral blood glucose meter configured so as to be capable of receiving therein a strip cartridge for holding a plurality of test strips, and to enable the test strips to be loaded one by one from the strip cartridge by linearly moving an operation knob, and thus has a simple operation method and structure and enables accurately supplying and discharging the test strips, and detects whether a strip loading unit is operating so as to calculate the number of remaining test strips in the strip cartridge, thereby enabling a user to identify the number of remaining test strips in advance and make preparations by anticipating the time when the strip cartridge has to be replaced, and thus enabling improved stability in use.



traducir


 

INTEGRAL BLOOD GLUCOSE METER

NºPublicación: WO2018199472A1 01/11/2018

Solicitante:
I SENS INC [KR]

Resumen de: WO2018199472A1

The present invention relates to an integral blood glucose meter, and provides an integral blood glucose meter configured so as to be capable of receiving therein a strip cartridge for holding a plurality of test strips, and to enable the test strips to be loaded one by one from the strip cartridge by linearly moving an operation knob, and thus has a simple operation method and structure and enables accurately supplying and discharging the test strips, and enables a sealing function for the strip cartridge to be stably maintained by enabling a supplying opening of the strip cartridge to be opened only during the operation of the operation knob, and thus enables the accuracy of a blood glucose measurement result to be increased since the degrading of the test strips may be prevented even during a long period of use.



traducir


 

Device and Method for Automatic Data Acquisition and/or Detection

NºPublicación: US2018311435A1 01/11/2018

Solicitante:
ABBOTT DIABETES CARE INC [US]

Resumen de: US2018311435A1

Methods and system for providing diabetes management including automatic time acquisition protocol and expiration date detection are provided.



traducir


 

System and Method for Tracking Changes in Average Glycemia in Diabetics

NºPublicación: US2018313815A1 01/11/2018

Solicitante:
UNIV OF VIRGINIA PATENT FOUNDATION [US]

Resumen de: US2018313815A1

A computer-implemented method for providing a real-time estimate of glycosylated hemoglobin (HbAlc) of a patient from a self-monitoring blood glucose (SMBG) measurement, and tracking changes in average glycemia of said patient over time is disclosed. The method includes the steps of; a computer computing a surrogate fasting measurement based on SMBG data received from the patient; a computer computing a glycation value using the said surrogate fasting measurement in a predetermined glycation equation; a computer outputting said glycation value as an initial estimate of HbAlc upon initialization of tracking of said patient's average glycemia; a computer updating said glycation value by using an updated SMBG value in said predetermined glycation equation, said updated SMBG value being based on a subsequent computed surrogate fasting measurement; and a computer computing an updated estimate of HbAlc using said initial estimate of HbAlc and said updated glycation value in a predetermined HbAlc estimation equation.



traducir


 

PHOTONIC EMBEDDED REFERENCE SENSOR

NºPublicación: EP3396356A1 31/10/2018

Solicitante:
INDIGO DIABETES N V [BE]

Resumen de: EP3396356A1

A sensing system (100) comprising a photonics integrated circuit, the photonics integrated circuit partially encapsulated by an encapsulation material (200) and the photonics integrated circuit comprising a first integrated sensor (410) accessible to a target analyte such as glucose, and being positioned in a part of the photonics integrated circuit not being encapsulated by an encapsulation material (200), and a second integrated sensor (420) accessible to a reference substance and being positioned in a part of the photonics integrated circuit that is encapsulated by an encapsulation material (200). The sensing system (100) is further adapted to, when in use, comprise the reference substance but less or no target analyte between the second integrated sensor (420) and the encapsulation material (200) as compared to the amount of target analyte being present at the first integrated sensor (410). Preferably the sensing system (100) is an implantable biocompatible glucose sensor.



traducir


 

MICROWAVE-BASED NON-INVASIVE BLOOD GLUCOSE CONCENTRATION METER

NºPublicación: PH12017000134A1 29/10/2018

Solicitante:
TECH INSTITUTE OF THE PHILIPPINES [PH]

Resumen de: PH12017000134A1

A microwave-based non-invasive blood glucose concentration measuring device characterized by a circuity containing a rechargeable power source, microwave signal generator, RF detector and power amplifier, a microcontroller unit, GSM module, a port for a printer access, LED indicators, buzzer and a microstrip resonator sensor, wherein a person's thumb is tapped and disposed allowing blood glucose concentration to be measured so that glucose level is shown in a digital display. A GSM module contained in the circuit allows the patient's doctor to be notified of the blood glucose level through SMS, and the average daily glucose level stored in the microcontroller's memory is printable using an external printer.



traducir


 

SYSTEMS AND METHODS FOR LEVERAGING SMARTPHONE FEATURES IN CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2018303417A1 25/10/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018303417A1

The present embodiments harness a wide variety of capabilities of modern smartphones, and combine these capabilities with information from a continuous glucose monitor to provide diabetics and related people with more information than the continuous glucose monitor can provide by itself. The increased information provides the diabetic with an increased likelihood of good diabetes management for better health.



traducir


 

MULTI-FUNCTION ANALYTE MONITOR DEVICE AND METHODS OF USE

NºPublicación: US2018303389A1 25/10/2018

Solicitante:
ABBOTT DIABETES CARE INC [US]

Resumen de: US2018303389A1

Methods, systems and devices for detecting an analyte sample, determining an analyte concentration associated with the detected analyte sample, storing the determined analyte concentration and a time associated with the determined analyte concentration, retrieving two or more stored analyte concentrations, and determining an adjusted dose level based at least in part on a current dose level and data associated with the two or more retrieved analyte concentrations are provided. For example, adjustments to dosage levels of long-acting insulin may be provided to assist in the management of diabetes and related conditions.



traducir


 

ANALYTE SENSOR

NºPublicación: US2018303394A1 25/10/2018

Solicitante:
DEXCOM INC [US]

Resumen de: US2018303394A1

The present invention relates generally to biointerface membranes utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, the invention relates to novel biointerface membranes, to devices and implantable devices including these membranes, methods for forming the biointerface membranes on or around the implantable devices, and to methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device.



traducir


 

COLOROMETRIC SENSOR FOR THE NON-INVASIVE SCREENING OF GLUCOSE IN SWEAT IN PRE AND TYPE 2 DIABETES

NºPublicación: US2018303388A1 25/10/2018

Solicitante:
MEDTRONIC MINIMED INC [US]

Resumen de: US2018303388A1

Described here are patches and methods for measuring glucose in sweat (and tears and the like). In general, the patches comprise an adhesive layer adapted to bond to skin of an individual, a substrate layer disposed over the adhesive layer and comprising a glucose sensing complex including a chromogen that changes color in the presence of certain concentrations of glucose, and a cover. In typical embodiments, the substrate layer has elements formed to direct and accumulate sweat that migrates from the skin of the individual to the glucose sensing complex. Methods of using the invention can comprise cleaning the skin surface, collecting sweat in a patch comprising this microfluidic constellation of elements, and observing concentrations of glucose collected in the sweat, for example either visually, or by using a smartphone or other computer processing device.



traducir


 

Apparatus and System for Monitoring an Insulin Sample in a Case

NºPublicación: US2018306651A1 25/10/2018

Solicitante:
BETESTRONGCASES LLC [US]

Resumen de: US2018306651A1

A monitoring system for monitoring the temperature of a sample of insulin stored in a container. Additionally, a monitoring and detecting system for monitoring a sample that is sensitive to ambient temperature, pressure and/or ultra-violet (UV) radiation or other conditions. The system includes sensor circuits that sense conditions of a sample. A comparator circuit receives input from the sensor circuit indicative of the sensed conditions of the sample. The comparator circuit generates a profile of the sample and indicator modules provide an indication, such as warn or fail for the sample.



traducir


 

GLUCOSE SENSOR

NºPublicación: US2018306802A1 25/10/2018

Solicitante:
LIGHTSHIP MEDICAL LTD [GB]

Resumen de: US2018306802A1

A method of quantifying the amount of glucose in a sample is provided herein that may further comprise an interferent such as mannitol. At least two measurements are obtained using measurement methods that differ in their sensitivity to the amount of interferent in the sample, thus enabling the results to be compared to determine whether any interferent is present in the sample. A glucose sensor for carrying out a method described herein is also provided



traducir


 

INSULIN LEAKAGE SENSOR WITH ELECTRIC CONTROL TO STOP INSULIN FLOW

NºPublicación: WO2018195310A1 25/10/2018

Solicitante:
BECTON DICKINSON CO [US]

Resumen de: WO2018195310A1

An insulin delivery device (10) includes a cannula (40) for delivering insulin to a patient at an infusion site, a pump assembly (30), and a valve (36) for controlling the flow of insulin. A removable leak detector unit (28) is coupled to the delivery device for sensing and detecting leakage of insulin at the infusion site. The leak detector unit (28) has electrodes (56) positioned for contacting the insulin leaking from the infusion site, a sensing electrical circuit (54) and a power source (58) for operating the leak detector unit. The removable leak detector unit (28) has an electrical contact (62) for mating with an electrical contact (64) of the delivery device for electrically and operatively connecting the leak detector unit (28) to the delivery device. The leak detector unit (28) sends a signal to the pump assembly (30) and/or valve (36) to stop the flow of insulin when leakage is detected at the infusion site.



traducir


 

SYSTEMS AND METHODS FOR REAL-TIME MONITORING OF PHYSIOLOGICAL BIOMARKERS THROUGH NERVE SIGNALS AND USES THEREOF

NºPublicación: WO2018195238A1 25/10/2018

Solicitante:
THE FEINSTEIN INSTITUTE FOR MEDICAL RES [US]

Resumen de: WO2018195238A1

The present disclosure relates to systems, methods and devices to monitor, diagnose and/or treat diseases or disorders comprising a calibration phase and a real-time diagnostic, treatment or monitoring phase, the calibration phase correlating a plurality of nerve activity measurements from a chronically implanted electrode in a subject with a plurality of concurrent measurements of levels of cytokines and/or glucose in the blood to obtain a functional relationship between blood cytokine and/or glucose levels and vagus nerve activity, and the diagnostic, treatment or monitoring phase analyzing the subject's real-time vagus nerve activity in accordance with the previously obtained functional relationship to initiate a treatment method.



traducir


 

SMART WRISTWATCH CAPABLE OF NONINVASIVELY COLLECTING BLOOD SUGAR DATA

NºPublicación: WO2018192255A1 25/10/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018192255A1

A smart wristwatch (100) capable of noninvasively collecting blood sugar data comprises a watch dial body (101), a watch band (102), a first button (103), and a second button (113). The watch band (102) is mounted to two sides of the watch dial body (101). The wristwatch (100) also comprises an infrared light transmission module (104), a signal conversion module (106), a communication module (107), a timer (108), a microcontroller (109) and a power supply module (110) that are disposed in the watch dial body (101), an infrared light reception module (105) disposed in the watch band (102), and a display screen (114) disposed on the upper surface of the watch dial body (101). The first button (103) and the second button (113) are disposed on the outer side of the watch dial body (101), the first button (103) is connected to the microcontroller (109) by means of a line, and the second button (113) is connected to the timer (108) by means of a line. The wristwatch (100) can conveniently and noninvasively collect the blood sugar concentration of the body of a user, thereby improving the portability and improving the user experience.



traducir


 

WRISTWATCH FOR NONINVASIVELY COLLECTING BLOOD SUGAR DATA

NºPublicación: WO2018192256A1 25/10/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018192256A1

A wristwatch (100) for noninvasively collecting blood sugar data comprises a watch dial body (101), a watch band (102), and a button (113). The watch band (102) is mounted to two sides of the watch dial body (101). The wristwatch (100) also comprises an infrared light transmission module (104), a signal conversion module (106), a communication module (107), a timer (108), a microcontroller (109) and a power supply module (110) that are disposed in the watch dial body (101), and an infrared light reception module (105) disposed in the watch band (102). The display screen (114) is disposed on the upper surface of the watch dial body (101). The button (113) is disposed on the outer side of the watch dial body (101), and is connected to the timer (108) by means of a line. By arranging the timer (108), the wristwatch (100) can automatically collect the blood sugar concentration of the body of a user at a fixed time point, so that the blood sugar concentration of the body of the user can be conveniently and noninvasively collected, thereby improving the ease of use and the portability, and improving the user experience.



traducir


 

SYRINGE NEEDLE UNIT TO WHICH BLOOD GLUCOSE SENSOR IS ATTACHED, AND SIMULTANEOUS BLOOD GLUCOSE MEASUREMENT SYRINGE DEVICE COMPRISING SAME

NºPublicación: WO2018194281A1 25/10/2018

Solicitante:
CHOI KYU DONG [KR]

Resumen de: WO2018194281A1

The present invention relates to a syringe needle unit to which a sensor is attached and, more particularly, to a syringe needle unit (100) to which a sensor is attached and a simultaneous blood glucose measurement syringe device comprising the same, the syringe needle unit comprising: a syringe needle (110) in which an injection through-hole, through which an injection liquid can pass, is formed along the central axis; and one or more blood glucose measurement sensor probes (120) attached to the outer peripheral surface of the syringe needle (110), and the present invention can simultaneously measure blood glucose with only a one-time insertion of the syringe needle whenever insulin and the like is injected without a separate blood glucose measurement device or procedure.



traducir


 

WRISTWATCH HAVING FUNCTION FOR NONINVASIVELY COLLECTING BLOOD SUGAR DATA

NºPublicación: WO2018192257A1 25/10/2018

Solicitante:
ANYCHECK INFORMATION TECH CO LTD [CN]

Resumen de: WO2018192257A1

A wristwatch (100) having a function for noninvasively collecting blood sugar data comprises a watch dial body (101), a watch band (102), and a button (103). The watch band (102) is mounted to two sides of the watch dial body (101). The wristwatch (100) also comprises an infrared light transmission module (104), an infrared light reception module (105), a signal conversion module (106), a communication module (107), a microcontroller (109) and a power supply module (110) that are connected by means of lines. The infrared light transmission module (104), the signal conversion module (106), the communication module (107), the microcontroller (109) and the power supply module (110) are disposed in the watch dial body (101). The infrared light reception module (105) is disposed in the watch band (102). The button (103) is disposed on the outer side of the watch dial body (101), and is connected to the microcontroller (109) by means of a line. The wristwatch (100) is convenient to carry and use by a user, and can conveniently and noninvasively collect the blood sugar concentration of the body of the user, thereby improving the portability and improving the user experience.



traducir


 

DIABETES THERAPY TRAINING DEVICE

NºPublicación: WO2018195255A1 25/10/2018

Solicitante:
BECTON DICKINSON CO [US]

Resumen de: WO2018195255A1

A portable device (20) for educating a user in diabetes management includes a display (26) presenting a user interface to provide a virtual patient (28) having diabetes and depicted as an avatar having the form of a boy or girl. A health status (30) is indicated by a bar graph (32). The user interface presents a feeding control (40) for providing food or drinks to the virtual patient; an exercise control (38) for causing the virtual patent to exercise; and a medication control for providing medication to the virtual patient. Each of the controls causing a corresponding change in the health status of the virtual patient having type-1 diabetes. An injection training application (34) is provided for teaching injection techniques. A testing training application (36) allows the user to check one or more health parameters of the virtual patient. Other applications, such as exercise and diet logging applications and an activities checklist are included as well.



traducir


 

DIABETES MANAGEMENT SYSTEM WITH AUTOMATIC BASAL AND MANUAL BOLUS INSULIN CONTROL

NºPublicación: WO2018194838A1 25/10/2018

Solicitante:
ANIMAS CORP [US]

Resumen de: WO2018194838A1

Systems and methods for diabetes management with automatic basal and manual bolus insulin control are presented. An exemplary system includes a delivery device, a glucose sensor, and a controller. The delivery device delivers insulin and the glucose sensor measures glucose levels of the subject. A basal insulin dose is calculated using a model predictive control algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels. A manual bolus insulin dose is initiated by the subject. The manual bolus insulin dose is modified based on one or both of the model predictive control algorithm and the physiological data of the subject. A total insulin dose is determined based on the modified manual bolus insulin dose and the calculated basal insulin dose, and delivered to the subject.



traducir


 

METHOD OF PREDICTING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE

Nº publicación: RU2670689C1 24/10/2018

Solicitante:
FEDERALNOE GOSUDARSTVENNOE BYUDZHETNOE OBRAZOVATELNOE UCHREZHDENIE VYSSHEGO OBRAZOVANIYA PERVYJ SANK [RU]

Resumen de: RU2670689C1

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely cardiology, cardiac surgery, angiology and rehabilitation. Determine the presence of type 2 diabetes, heredity, burdened with IHD, LDL cholesterol, factor of smoking and, additionally, the presence of polymorphisms of the receptor activator gene of peroxisome proliferation PPAR-γ2 and PPAR-α and the number of affected coronary arteries at the time of manifestation of the disease. Then, calculate the discriminant function according to the original formula and, with its positive values, predict CC in patients with IHD, with its negative values, the absence of CC.EFFECT: method makes it possible to predict the CC in patients with IHD with different coronary artery disease severity with high accuracy, which allows selecting a priority group of patients for personalized secondary prevention of adverse CC.1 cl, 2 dwg, 1 tbl, 2 ex


traducir



 

Página1 de 4 nextPage Mostrar por página

Volver